Clover Health Investments, Corp. (CLOV)

USD 3.15

(-1.87%)

EBITDA Summary of Clover Health Investments, Corp.

Clover Health Investments, Corp.'s latest annual EBITDA in 2023 was -210.84 Million USD , up 51.27% from previous year.
Clover Health Investments, Corp.'s latest quarterly EBITDA in 2024 Q2 was 7.99 Million USD , up 135.69% from previous quarter.
Clover Health Investments, Corp. reported an annual EBITDA of -337.01 Million USD in 2022, up 41.84% from previous year.
Clover Health Investments, Corp. reported an annual EBITDA of -569.6 Million USD in 2021, down -589.89% from previous year.
Clover Health Investments, Corp. reported a quarterly EBITDA of 7.99 Million USD for 2024 Q2, up 135.69% from previous quarter.
Clover Health Investments, Corp. reported a quarterly EBITDA of -39.59 Million USD for 2023 Q3, down -71.74% from previous quarter.

Annual EBITDA Chart of Clover Health Investments, Corp. (2023 - 2018)

Historical Annual EBITDA of Clover Health Investments, Corp. (2023 - 2018)

Year	EBITDA	EBITDA Growth
2023	-210.84 Million USD	51.27%
2022	-337.01 Million USD	41.84%
2021	-569.6 Million USD	-589.89%
2020	-78.72 Million USD	49.55%
2019	-182.64 Million USD	-1032.28%
2018	-16.13 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-21.21 Million USD	67.93%
2024 Q2	7.99 Million USD	135.69%
2023 Q3	-39.59 Million USD	-71.74%
2023 Q2	-23.05 Million USD	68.12%
2023 FY	- USD	51.27%
2023 Q1	-72.32 Million USD	32.51%
2023 Q4	-46.98 Million USD	-18.64%
2022 Q3	-73.29 Million USD	28.24%
2022 Q2	-102.14 Million USD	-18.12%
2022 Q1	-86.47 Million USD	53.49%
2022 Q4	-107.16 Million USD	-46.2%
2022 FY	- USD	41.84%
2021 Q1	-118.92 Million USD	-76.22%
2021 FY	- USD	-589.89%
2021 Q4	-185.94 Million USD	-24.68%
2021 Q3	-149.13 Million USD	17.94%
2021 Q2	-181.74 Million USD	-52.82%
2020 Q3	-21.48 Million USD	-192.1%
2020 Q2	23.32 Million USD	187.98%
2020 Q1	-26.5 Million USD	-150248.82%
2020 FY	- USD	49.55%
2020 Q4	-67.48 Million USD	-214.19%
2019 Q2	-72.41 Million USD	0.0%
2019 Q4	-17.63 Thousand USD	99.92%
2019 Q3	-20.81 Million USD	71.26%
2019 Q1	-72.41 Million USD	0.0%
2019 FY	- USD	-1032.28%
2018 FY	- USD	0.0%

Peer EBITDA Comparison of Clover Health Investments, Corp.

Name	EBITDA	EBITDA Difference
Alignment Healthcare, Inc.	-105.29 Million USD	-100.24%
Marpai, Inc.	-20.97 Million USD	-905.244%
NewGenIvf Group Limited	-2.52 Million USD	-8261.556%